Stachyra-Strawa, P.; Szatkowska-Sieczek, L.; Cisek, P.; Gołębiowski, P.; Grzybowska-Szatkowska, L.
Cardiac and Nephrological Complications Related to the Use of Antiangiogenic and Anti-Programmed Cell Death Protein 1 Receptor/Programmed Cell Death Protein 1 Ligand Therapy. Genes 2024, 15, 177.
https://doi.org/10.3390/genes15020177
AMA Style
Stachyra-Strawa P, Szatkowska-Sieczek L, Cisek P, Gołębiowski P, Grzybowska-Szatkowska L.
Cardiac and Nephrological Complications Related to the Use of Antiangiogenic and Anti-Programmed Cell Death Protein 1 Receptor/Programmed Cell Death Protein 1 Ligand Therapy. Genes. 2024; 15(2):177.
https://doi.org/10.3390/genes15020177
Chicago/Turabian Style
Stachyra-Strawa, Paulina, Lidia Szatkowska-Sieczek, Paweł Cisek, Paweł Gołębiowski, and Ludmiła Grzybowska-Szatkowska.
2024. "Cardiac and Nephrological Complications Related to the Use of Antiangiogenic and Anti-Programmed Cell Death Protein 1 Receptor/Programmed Cell Death Protein 1 Ligand Therapy" Genes 15, no. 2: 177.
https://doi.org/10.3390/genes15020177
APA Style
Stachyra-Strawa, P., Szatkowska-Sieczek, L., Cisek, P., Gołębiowski, P., & Grzybowska-Szatkowska, L.
(2024). Cardiac and Nephrological Complications Related to the Use of Antiangiogenic and Anti-Programmed Cell Death Protein 1 Receptor/Programmed Cell Death Protein 1 Ligand Therapy. Genes, 15(2), 177.
https://doi.org/10.3390/genes15020177
